Genomic and Immune Cell Landscape of Response to Chemo-Immunotherapy in Malignant Pleural Mesothelioma

被引：0

作者：

Niknafs, N. ^{[1
]}

Forde, P. ^{[1
]}

Lanis, M. ^{[1
]}

Belcaid, Z. ^{[1
]}

Smith, K. ^{[1
]}

Sun, Z. ^{[2
]}

Balan, A. ^{[1
]}

White, J. ^{[1
]}

Cherry, C. ^{[1
]}

Shivakumar, A. ^{[1
]}

Shao, X. ^{[1
]}

Kindler, H. ^{[3
]}

Purcell, T. ^{[4
]}

Santana-Davila, R. ^{[5
]}

Dudek, A. ^{[6
]}

Borghaei, H. ^{[7
]}

Illei, P. ^{[1
]}

Velculescu, V. ^{[1
]}

Karchin, R. ^{[1
]}

Brahmer, J. ^{[1
]}

Ramalingam, S. ^{[8
]}

Anagnostou, V. ^{[1
]}

机构：

[1] Johns Hopkins Canc Ctr, Thorac Oncol, Baltimore, MD USA

[2] Frontier Sci Fdn, Ecog Acrin Biostat Ctr, Boston, MA USA

[3] Univ Chicago, Chicago, IL 60637 USA

[4] Univ Colorado, Ctr Canc, Denver, CO 80262 USA

[5] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA

[6] Metro Minnesota Community Oncol Res Consortium, St Luis Pk, MN USA

[7] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA

[8] Emory Univ, Sch Med, Dept Hematol & Med Oncol, Atlanta, GA USA

来源：

JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期

关键词：

mesothelioma; immunotherapy; multi-omics; genomics;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OA12.01

引用

页码：S867 / S868

页数：2

共 50 条

[1] Complete Pathological Response After Neoadjuvant Chemo-Immunotherapy in Malignant Pleural Mesothelioma
Tostes, Francinne T.
Zugman, Miguel
Paes, Vitor R.
Schvartsman, Gustavo
FRONTIERS IN ONCOLOGY, 2022, 12
[2] Radio-immunotherapy and chemo-immunotherapy as a novel treatment paradigm in malignant pleural mesothelioma
Wu, Licun
de Perrot, Marc
TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (03) : 325 - 334
[3] Characterization of the Genomic and Immune Landscape of Malignant Pleural Mesothelioma
Bille, A.
Torricelli, F.
Ramsay, A. G.
Ellis, R.
Spada, F.
Perov, N.
Barberio, M. Terranovo
Todd, K.
Bishop, C.
Nonaka, D.
Apollonio, B.
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S390 - S391
[4] Genomic landscape and immune phenotype of malignant pleural mesothelioma.
Patel, Meera
Elliott, Andrew
Liu, Stephen, V
Kim, Chul
Raez, Luis E.
Feldman, Rebecca
Pai, Sachin Gopalkrishna
Wozniak, Antoinette J.
Nagasaka, Misako
Lopes, Gilberto
Spira, Alexander, I
Kim, Edward S.
Korn, Wolfgang Michael
Mamdani, Hirva
JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
[5] MESOTHELIN TARGETED CHEMO-IMMUNOTHERAPY FOR TREATMENT OF MALIGNANT MESOTHELIOMA AND LUNG ADENOCARCINOMA
Hassan, R.
Sharon, E.
Pastan, I.
ANNALS OF ONCOLOGY, 2010, 21 : 42 - 42
[6] Chemo-immunotherapy of advanced malignant melanoma
Kirchner, HH
Atzpodien, J
Poliwoda, H
MEDIZINISCHE KLINIK, 1996, 91 : 44 - 49
[7] Immunotherapy in Malignant Pleural Mesothelioma
de Gooijer, Cornedine J.
Borm, Frank J.
Scherpereel, Arnaud
Baas, Paul
FRONTIERS IN ONCOLOGY, 2020, 10
[8] Immunotherapy in malignant pleural mesothelioma
Farooqi, Saima Jamil
Helland, Aslaug
Haakensen, Vilde Drageset
Bjaanaes, Maria Moksnes
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (12) : 1167 - 1169
[9] Progress in the Understanding of the Immune Microenvironment and Immunotherapy in Malignant Pleural Mesothelioma
Cheng, Lei
Li, Na
Xu, Xiao-Ling
Mao, Wei-Min
CURRENT DRUG TARGETS, 2020, 21 (15) : 1606 - 1612
[10] COMBINATION CHEMO-IMMUNOTHERAPY OF MALIGNANT-MELANOMA
NATHANSON, L
CUNNINGHAM, T
KUPERMINC, M
FALKSON, G
SCHOENFELD, D
MARSH, J
DEWYS, W
WOLTER, J
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1979, 20 (MAR): : 314 - 314

← 1 2 3 4 5 →